These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22037484)

  • 1. Identification and functional characterization of the human EXT1 promoter region.
    Jennes I; Zuntini M; Mees K; Palagani A; Pedrini E; De Cock G; Fransen E; Vanden Berghe W; Sangiorgi L; Wuyts W
    Gene; 2012 Jan; 492(1):148-59. PubMed ID: 22037484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb).
    Jennes I; Pedrini E; Zuntini M; Mordenti M; Balkassmi S; Asteggiano CG; Casey B; Bakker B; Sangiorgi L; Wuyts W
    Hum Mutat; 2009 Dec; 30(12):1620-7. PubMed ID: 19810120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas.
    Wuyts W; Radersma R; Storm K; Vits L
    Clin Genet; 2005 Dec; 68(6):542-7. PubMed ID: 16283885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 20 novel point mutations and one large deletion in EXT1 and EXT2 genes: report of diagnostic screening in a large Italian cohort of patients affected by hereditary multiple exostosis.
    Ciavarella M; Coco M; Baorda F; Stanziale P; Chetta M; Bisceglia L; Palumbo P; Bengala M; Raiteri P; Silengo M; Caldarini C; Facchini R; Lala R; Cavaliere ML; De Brasi D; Pasini B; Zelante L; Guarnieri V; D'Agruma L
    Gene; 2013 Feb; 515(2):339-48. PubMed ID: 23262345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes.
    Wuyts W; Van Hul W
    Hum Mutat; 2000; 15(3):220-7. PubMed ID: 10679937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells.
    Ropero S; Setien F; Espada J; Fraga MF; Herranz M; Asp J; Benassi MS; Franchi A; Patiño A; Ward LS; Bovee J; Cigudosa JC; Wim W; Esteller M
    Hum Mol Genet; 2004 Nov; 13(22):2753-65. PubMed ID: 15385438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline mutations in the EXT1 and EXT2 genes in Korean patients with hereditary multiple exostoses.
    Park KJ; Shin KH; Ku JL; Cho TJ; Lee SH; Choi IH; Phillipe C; Monaco AP; Porter DE; Park JG
    J Hum Genet; 1999; 44(4):230-4. PubMed ID: 10429361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From gene to disease; hereditary multiple exostoses].
    Wuyts W; Bovée JV; Hogendoorn PC
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):162-4. PubMed ID: 11845565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic organization and promoter structure of the human EXT1 gene.
    Lüdecke HJ; Ahn J; Lin X; Hill A; Wagner MJ; Schomburg L; Horsthemke B; Wells DE
    Genomics; 1997 Mar; 40(2):351-4. PubMed ID: 9119404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis.
    Stickens D; Brown D; Evans GA
    Dev Dyn; 2000 Jul; 218(3):452-64. PubMed ID: 10878610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation screening of EXT1 and EXT2 by direct sequence analysis and MLPA in patients with multiple osteochondromas: splice site mutations and exonic deletions account for more than half of the mutations.
    Vink GR; White SJ; Gabelic S; Hogendoorn PC; Breuning MH; Bakker E
    Eur J Hum Genet; 2005 Apr; 13(4):470-4. PubMed ID: 15586175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 multiple osteochondromas families.
    Jennes I; de Jong D; Mees K; Hogendoorn PC; Szuhai K; Wuyts W
    BMC Med Genet; 2011 Jun; 12():85. PubMed ID: 21703028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel EXT1 and EXT2 mutations identified by DHPLC in Italian patients with multiple osteochondromas.
    Pedrini E; De Luca A; Valente EM; Maini V; Capponcelli S; Mordenti M; Mingarelli R; Sangiorgi L; Dallapiccola B
    Hum Mutat; 2005 Sep; 26(3):280. PubMed ID: 16088908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiling resolution array-CGH shows that somatic mosaic deletion of the EXT gene is causative in EXT gene mutation negative multiple osteochondromas patients.
    Szuhai K; Jennes I; de Jong D; Bovée JV; Wiweger M; Wuyts W; Hogendoorn PC
    Hum Mutat; 2011 Feb; 32(2):E2036-49. PubMed ID: 21280143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional SNP in the promoter region of TCOF1 is associated with reduced gene expression and YY1 DNA-protein interaction.
    Masotti C; Armelin-Correa LM; Splendore A; Lin CJ; Barbosa A; Sogayar MC; Passos-Bueno MR
    Gene; 2005 Oct; 359():44-52. PubMed ID: 16102917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Next-Generation Sequencing Newly Identifies Mutations in Exostosin-1 and Exostosin-2 Genes of Patients with Multiple Osteochondromas.
    Guo X; Lin M; Shi T; Yan W; Chen W
    Tohoku J Exp Med; 2017 Jul; 242(3):173-181. PubMed ID: 28690282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation screening of EXT1 and EXT2 by denaturing high-performance liquid chromatography, direct sequencing analysis, fluorescence in situ hybridization, and a new multiplex ligation-dependent probe amplification probe set in patients with multiple osteochondromas.
    Jennes I; Entius MM; Van Hul E; Parra A; Sangiorgi L; Wuyts W
    J Mol Diagn; 2008 Jan; 10(1):85-92. PubMed ID: 18165274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel EXT1 mutation identified in a pedigree with hereditary multiple exostoses.
    Cao L; Liu F; Kong M; Fang Y; Gu H; Chen Y; Zhao C; Zhang S; Bi Q
    Oncol Rep; 2014 Feb; 31(2):713-8. PubMed ID: 24297320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel mutation in the EXT1 gene from a patient with multiple osteochondromas by exome sequencing.
    Hong G; Guo X; Yan W; Li Q; Zhao H; Ma P; Hu X
    Mol Med Rep; 2017 Feb; 15(2):657-664. PubMed ID: 28035357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.